科研成果详情

题名FGF21 inhibits ferroptosis caused by mitochondrial damage to promote the repair of peripheral nerve injury
作者
发表日期2024-09-23
发表期刊FRONTIERS IN PHARMACOLOGY   影响因子和分区
语种英语
原始文献类型Article
关键词peripheral nerve injury ferroptosis mitochondria fibroblast growth factor 21 (FGF21) schwann cell ROS lipid peroxidation
其他关键词CELL-DEATH ; SCHWANN-CELLS ; FGF-21 ; NEXUS ; IRON
摘要Introduction Ferroptosis is a new type of cell death characterized by lipid peroxidation and iron dependency, representing an emerging disease regulation mechanism. The limited understanding of ferroptosis in peripheral nerve injury (PNI) complicates the management of such injuries. Mitochondrial dysfunction, which contributes to ferroptosis, further exacerbates the challenges of peripheral nerve repairMethods In this study, we established an in vitro model of Schwann cells model treated with TBHP and an in vivo sciatic nerve crush injury model in rats. These models were used to investigate the effects of fibroblast growth factor 21 (FGF21) on PNI, both in vitro and in vivo, and to explore the potential mechanisms linking injury-induced ferroptosis and mitochondrial dysfunction.Results Our findings reveal that PNI triggers abnormal accumulation of lipid reactive oxygen species (ROS) and inactivates mitochondrial respiratory chain complex III, leading to mitochondrial dysfunction. This dysfunction catalyzes the oxidation of excessive polyunsaturated fatty acids, resulting in antioxidant imbalance and loss of ferroptosis suppressor protein 1 (FSP1), which drives lipid peroxidation. Additionally, irregular iron metabolism, defective mitophagy, and other factors contribute to the induction of ferroptosis. Importantly, we found that FGF21 attenuates the abnormal accumulation of lipid ROS, restores mitochondrial function, and suppresses ferroptosis, thus promoting PNI repair. Notably, glutathione peroxidase 4 (GPX4), a downstream target of nuclear factor E2-related factor 2 (Nrf2), and the ERK/Nrf2 pathway are involved in the regulation of ferroptosis by FGF21.Conclusion FGF21 promotes peripheral nerve repair by inhibiting ferroptosis caused by mitochondrial dysfunction. Therefore, targeting mitochondria and ferroptosis represents a promising therapeutic strategy for effective PNI repair.
资助项目National Natural Science Foundation of China [82171375]
出版者FRONTIERS MEDIA SA
EISSN1663-9812
卷号15
DOI10.3389/fphar.2024.1358646
页数22
WOS类目Pharmacology & Pharmacy
WOS研究方向Pharmacology & Pharmacy
WOS记录号WOS:001326733400001
收录类别SCIE
PubMed ID39376607
通讯作者地址[Wang, Jian]Wenzhou Med Univ, Dept Wound Repair, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China. ; [Wang, Jian]Wenzhou Med Univ, Cixi Biomed Res Inst, Wenzhou, Zhejiang, Peoples R China. ; [Wang, Jian]Wenzhou Med Univ, Wenzhou, Zhejiang, Peoples R China.
引用统计
文献类型期刊论文
条目标识符https://kms.wmu.edu.cn/handle/3ETUA0LF/220810
专题附属第一医院
温州医科大学
其他_温州医科大学慈溪生物医药研究院
通讯作者Wang, Jian
作者单位
1.Wenzhou Med Univ, Dept Wound Repair, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China;
2.Wenzhou Med Univ, Cixi Biomed Res Inst, Wenzhou, Zhejiang, Peoples R China;
3.Wenzhou Med Univ, Wenzhou, Zhejiang, Peoples R China
第一作者单位附属第一医院;  其他_温州医科大学慈溪生物医药研究院;  温州医科大学
通讯作者单位附属第一医院;  其他_温州医科大学慈溪生物医药研究院;  温州医科大学
第一作者的第一单位附属第一医院
推荐引用方式
GB/T 7714
Yan, Yao,Ran, Xinyu,Zhou, Zihan,et al. FGF21 inhibits ferroptosis caused by mitochondrial damage to promote the repair of peripheral nerve injury[J]. FRONTIERS IN PHARMACOLOGY,2024,15.
APA Yan, Yao., Ran, Xinyu., Zhou, Zihan., Gu, Yuting., Wang, Rendu., ... & Wang, Jian. (2024). FGF21 inhibits ferroptosis caused by mitochondrial damage to promote the repair of peripheral nerve injury. FRONTIERS IN PHARMACOLOGY, 15.
MLA Yan, Yao,et al."FGF21 inhibits ferroptosis caused by mitochondrial damage to promote the repair of peripheral nerve injury".FRONTIERS IN PHARMACOLOGY 15(2024).

条目包含的文件

条目无相关文件。
个性服务
查看访问统计
谷歌学术
谷歌学术中相似的文章
[Yan, Yao]的文章
[Ran, Xinyu]的文章
[Zhou, Zihan]的文章
百度学术
百度学术中相似的文章
[Yan, Yao]的文章
[Ran, Xinyu]的文章
[Zhou, Zihan]的文章
必应学术
必应学术中相似的文章
[Yan, Yao]的文章
[Ran, Xinyu]的文章
[Zhou, Zihan]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。